236 results
Selective Publication of Antidepressant Trials

A more complete picture: contrasting the journal version of antidepressant trials with
trials with the FDA ... #Policy #EBM #Psychiatry ... Bias #Comparison #FDA
Selective Publication of Antidepressant Trials

A more complete picture: contrasting the journal version of antidepressant trials with
trials with the FDA ... #Policy #EBM #Psychiatry ... Bias #Comparison #FDA
SNRls (Serotonin/Norepinephrine Reuptake Inhibitors) - FDA Approved Indications 

Venlafaxine (Effexor) - GAD, MDD, Panic Disorder, SAD
Inhibitors) - FDA ... #Pharmacology #Psychiatry ... #FDA #Approved
With the recent publication of the FDA Guidance on alcohol-based hand sanitizer compounding, I thought to
publication of the FDA ... with both the FDA ... FDA is also encouraging
Figure 2: Sex differences in the lifetime incidence of psychiatric disorders vary from higher incidence in
lifetime incidence of psychiatric ... #Diagnosis #Psychiatry ... #Psychiatric #Disorders
Trauma & Stressor Related Psychiatric Disorders - Differential Diagnosis Algorithm

 - Adjustment Disorder - Development of
Stressor Related Psychiatric ... Diagnosis #Algorithm #Psychiatry
Culture-Bound Syndromes found in DSM-5, published by the American Psychiatric Association (APA). 
#Psychiatry #Diagnosis #CulturalCompetence #CultureBound
by the American Psychiatric ... #Psychiatry #Diagnosis
Alprazolam - short-acting benzodiazepine (GABA Receptor Modulator) used in the treatment of anxiety disorders. FDA approved
FDA approved in
Elagolix (Orilissa) - Pharmacology Review
Elagolix is a small-molecule GnRH antagonist recently approved by the FDA for
approved by the FDA
Third Generation Antipsychotics: Mechanisms and Side Effects
(Atypical Anti-Psychotics) Example: Aripiprazole
Dopamine D2 Receptor Partial Agonist
 • Binds
Prevents excess DA ... and deficient DA ... pharmacology #diagnosis #psychiatry